作者: Fernández López María Belén , Navarro Hilfiker Sabine , Chartier-Harlin Marie-Christine , Lara Ordóñez Antonio Jesús , Mutez Eugénie
DOI:
关键词:
摘要: The present invention relates to a leucine-rich repeat kinase 2 (LRRK2) inhibitor for use in the treatment and/or prevention of Parkinson's disease, or diseases related subject having centrosomal cohesion deficit, as well an vitro method designing customized therapy with Disease, opening new therapeutic window this disease.